Skip to content
AceLink Therapeutics logo

AceLink Therapeutics Alternatives & Competitors

12 companies similar to AceLink Therapeutics — Overcome genetic diseases, one at a time

Companies similar to AceLink Therapeutics

Sharp Therapeutics logo — alternative to AceLink Therapeutics

Sharp Therapeutics

Developing small molecule drugs for genetic diseases..

Saverna Therapeutics AG logo — alternative to AceLink Therapeutics

Saverna Therapeutics AG

Saverna Therapeutics aims to discover highly active, selective and cell-permeable molecule...

Signet Therapeutics logo — alternative to AceLink Therapeutics

Signet Therapeutics

Pioneering the future of cancer treatment with breakthrough targeted therapies and innovat...

Sirtris Pharmaceuticals logo — alternative to AceLink Therapeutics

Sirtris Pharmaceuticals

Developing innovative, orally available small molecule drugs to combat aging-related disea...

Rival Readout

Competing with AceLink Therapeutics? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Purespring Therapeutics logo — alternative to AceLink Therapeutics

Purespring Therapeutics

We are Purespring. We are on a mission to radically transform the treatment of kidney dis...

XWPharma logo — alternative to AceLink Therapeutics

XWPharma

Neuroscience biotech developing novel therapeutics for sleep, neuropsych, and other unders...

Diatos logo — alternative to AceLink Therapeutics

Diatos

Pioneering advancements in cancer treatment through innovative drug targeting and enhanced...

Nexo Therapeutics logo — alternative to AceLink Therapeutics

Nexo Therapeutics

We’re driven to translate the most compelling and still undrugged targets in human biolog...

Trethera logo — alternative to AceLink Therapeutics
Tetralogic Pharmaceuticals logo — alternative to AceLink Therapeutics
Atom Therapeutics logo — alternative to AceLink Therapeutics

Atom Therapeutics

Atom Therapeutics Co., Ltd

Praxis Precision Medicines, Inc. logo — alternative to AceLink Therapeutics

Praxis Precision Medicines, Inc.

The era of genetic neuroscience has arrived

About AceLink Therapeutics

AceLink Therapeutics is a biopharmaceutical startup based in the San Francisco Bay Area, founded in 2019. The company's mission is to develop innovative drugs to combat genetically associated human diseases. Their initial focus is on creating a small molecule drug for polycystic kidney disease (PKD), a condition affect...

Business keywords

Biopharmaceutical, Startup, Drug Development, Genetic Diseases, Small Molecule Drugs, Polycystic Kidney Disease, San Francisco Bay Area, Precision Medicine

Frequently Asked Questions

Companies similar to AceLink Therapeutics include Sharp Therapeutics, Saverna Therapeutics AG, Signet Therapeutics, Sirtris Pharmaceuticals, Purespring Therapeutics. They share AceLink Therapeutics's focus on small molecule drugs, precision medicine and biopharmaceutical.
Bounce Watch lists 12 companies that share AceLink Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.
AceLink Therapeutics is a biopharmaceutical startup based in the San Francisco Bay Area, founded in 2019. The company's mission is to develop innovative drugs to combat genetically associated human diseases. Their initial focus is on creating a small molecule drug for polycystic kidney disease (PKD), a condition affect...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around AceLink Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at AceLink Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 14 Jun 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout